Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study.

L K P Regli,S M H Huijs,R C O S Pasmans,C Leue,J B Dijkstra,D B P Eekers,K E Hovinga,M H M E Anten,A Hoeben,M P G Broen

Journal of neuro-oncology（2023）

Cited 2|Views4

No score

Abstract

The found incidence of 11.5% and the high number of patients discontinuing treatment due to psychiatric symptoms justify more research in this, to date, understudied topic in scientific literature. Further prospective studies are needed to identify risk factors and unravel possible effects on survival.

Translated text

Key words

Glioblastoma, Psychiatric symptoms, Chemoradiation, Psychosis, Temozolomide

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined